Cargando…

Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

BACKGROUND: The pathophysiology of type 2 diabetes differs markedly by ethnicity. PURPOSE: A systematic review and meta-analysis was conducted to assess the impact of ethnicity on the glucose-lowering efficacy of the newer oral agents, sodium–glucose cotransporter 2 inhibitors (SGLT-2i), glucagon-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Sushrima, Dawed, Adem Y., Donnelly, Louise A., Nair, Anand T.N., Palmer, Colin N.A., Mohan, Viswanathan, Pearson, Ewan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Meta-Analyses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372059/ https://www.ncbi.nlm.nih.gov/pubmed/33534728 http://dx.doi.org/10.2337/dc19-2419

Ejemplares similares

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
por: Gan, Sushrima, et al.
Publicado: (2020)

The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus
por: Thakarakkattil Narayanan Nair, Anand, et al.
Publicado: (2020)

Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study
por: Newman, Terri Victoria, et al.
Publicado: (2021)

Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
por: Rietz, Marlene, et al.
Publicado: (2022)

Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients
por: Lu, Yang, et al.
Publicado: (2023)

Association Between Physical Activity and Risk of All-Cause Mortality and Cardiovascular Disease in Patients With Diabetes: A meta-analysis
por: Kodama, Satoru, et al.
Publicado: (2013)

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: de Vries, Marieke, et al.
Publicado: (2020)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND GLP1-RA IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
por: Trombara, Filippo, et al.
Publicado: (2023)

FRI648 GLP-1RA And SGLT2i Treatments May Show Improved Depression Metrics In Diabetes Treatment
por: Jain, Arad, et al.
Publicado: (2023)

Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
por: Chadha, Manoj, et al.
Publicado: (2022)

Monitoring the Comparative Safety of SGLT2i vs GLP-1 RA in Older Adults With Type 2 Diabetes by Frailty Status
por: Kutz, Alexander, et al.
Publicado: (2021)

SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
por: Anson, Matthew, et al.
Publicado: (2023)

Intraoperative Goal-directed Fluid Therapy in Elective Major Abdominal Surgery: A Meta-analysis of Randomized Controlled Trials
por: Rollins, Katie E., et al.
Publicado: (2016)

The effects of elective abdominal surgery on protein turnover: A meta-analysis of stable isotope techniques to investigate postoperative catabolism
por: Jaconelli, Matthew, et al.
Publicado: (2022)

Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
por: Koike, Masao, et al.
Publicado: (2021)

Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal Protection in Type 2 Diabetes) Cross-Sectional Study
por: Simões de Carvalho, Francisco, et al.
Publicado: (2023)

SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
por: El Mouhayyar, Christopher, et al.
Publicado: (2020)

Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
por: Young, Katherine G, et al.
Publicado: (2023)

Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
por: Young, Katherine G., et al.
Publicado: (2023)

Meta-analysis assessing the effectiveness of SGLT2i+GLP1RA combination therapy versus monotherapy on cardiovascular and cerebrovascular outcomes in diabetic patients
por: Du, Lixin, et al.
Publicado: (2022)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND DPP4I IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019)

A Systematic Review and Meta-analysis of the Association Between Depression and Insulin Resistance
por: Kan, Carol, et al.
Publicado: (2013)

The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
por: Matcham, Faith, et al.
Publicado: (2013)

Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy
por: Torlot, F J, et al.
Publicado: (2013)

Thermic effect of a meal and appetite in adults: an individual participant data meta-analysis of meal-test trials
por: Ravn, Anne-Marie, et al.
Publicado: (2013)

Prevalence of obesity among students aged 6 to 12 in China: a meta-analysis
por: Tian, Yue, et al.
Publicado: (2015)

The effect of ginger supplementation on serum C-reactive protein, lipid profile and glycaemia: a systematic review and meta-analysis
por: Mazidi, Mohsen, et al.
Publicado: (2016)

The most critical question when reading a meta-analysis report: Is it comparing apples with apples or apples with oranges?
por: Kızılırmak, Pınar, et al.
Publicado: (2015)

Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis
por: Koopman, Anitra D M, et al.
Publicado: (2019)

Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis
por: Broersen, Leonie H A, et al.
Publicado: (2020)

Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents
por: Al Khalifah, Reem A, et al.
Publicado: (2020)

Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study
por: Al Wattar, Bassel H, et al.
Publicado: (2021)

A Systematic Review and Meta-analysis of Randomized Controlled Trials Comparing Intraoperative Red Blood Cell Transfusion Strategies
por: Lenet, Tori, et al.
Publicado: (2022)

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Social media–based interventions for patients with cancer: a meta-analysis and meta-regression of randomised controlled trials
por: Siew, Li En Dana, et al.
Publicado: (2022)

Doppler parameters of ophthalmic artery in women with preeclampsia: A meta‐analysis
por: Dai, Xinxin, et al.
Publicado: (2022)

Meta‐analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism
por: Zhu, Qiu‐Gen, et al.
Publicado: (2022)

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
por: Schernthaner, Guntram, et al.
Publicado: (2020)

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials: Perspective on GLP-1 RA and SGLT-2i therapies
por: Ludwig, Lisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tqkgvj928dln2576807ckosrq